Cargando…
Autologous Stem Cells Transplantation for No-Option Angiitis-Induced Critical Limb Ischemia: Recurrence and New Lesion
Although satisfying outcomes have been demonstrated in terms of autologous stem cell transplantation in the treatment of angiitis-induced critical limb ischemia (AICLI), few studies have systematically reported the recurrence conditions. In the current study, we aimed to investigate recurrence condi...
Autores principales: | Liu, Hao, Fang, Yuan, Pan, Tianyue, Fang, Gang, Liu, Yifan, Jiang, Xiaolang, Chen, Bin, Gu, Shiyang, Wei, Zheng, Liu, Peng, Fu, Weiguo, Yang, Jue, Dong, Zhihui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154329/ https://www.ncbi.nlm.nih.gov/pubmed/35446404 http://dx.doi.org/10.1093/stcltm/szac017 |
Ejemplares similares
-
Three‐year outcomes of peripheral blood mononuclear cells vs purified CD34
(+) cells in the treatment of angiitis‐induced no‐option critical limb ischemia and a cost‐effectiveness assessment: A randomized single‐blinded noninferiority trial
por: Liu, Hao, et al.
Publicado: (2021) -
Autologous peripheral blood-derived stem cells transplantation for treatment of no-option angiitis-induced critical limb ischemia: 10-year management experience
por: Fang, Gang, et al.
Publicado: (2020) -
Long-Term Outcomes of Peripheral Blood Mononuclear Cells in the Treatment of Angiitis-Induced No-Option Critical Limb-Threatening Ischemia
por: Jiang, Xiaolang, et al.
Publicado: (2021) -
A Five‐Year Study of the Efficacy of Purified CD34+ Cell Therapy for Angiitis‐Induced No‐Option Critical Limb Ischemia
por: Fang, Yuan, et al.
Publicado: (2018) -
Return to work after cell transplantation in patients with angiitis-induced critical limb ischaemia and factors related: a single-centre retrospective cohort study
por: Liu, Hao, et al.
Publicado: (2022)